Investors could do ‘a lot worse’ than FedEx here, Jim Cramer says

Investors could do ‘a lot worse’ than FedEx here, Jim Cramer says


CNBC’s Jim Cramer on Monday told investors that while the market has yet to overcome the challenges threatening to create a recession, FedEx stock might be able to weather the turbulence.

“You might think FedEx would be a helpless victim of high gas prices, potential e-commerce plateau, a [Federal Reserve]-mandated slowdown. That would be wrong. This company’s taking control of its own destiny. … I think you could do a lot worse,” he said.

The “Mad Money” host said that while FedEx has struggled with supply chain disruptions and performing as well as it did during the height of the pandemic, the company is on the up and up.

FedEx reported mixed results in its latest quarter last week, beating slightly on earnings but missing on revenue, according to Refinitiv estimates. The company also issued a cheerful full-year guidance, projecting an increase in adjusted earnings. 

The transportation company also raised its dividend from 75 cents to $1.15.

“Companies don’t put through a 53% dividend boost when they’re worried about making their next quarter,” Cramer said. 

“Don’t forget, this is a market that only values profitable companies that reward their shareholders with dividends and buybacks,” he added.

Shares of FedEx fell 1.14% on Monday.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More